Cargando…
The basics of preclinical drug development for neurodegenerative disease indications
Preclinical development encompasses the activities that link drug discovery in the laboratory to initiation of human clinical trials. Preclinical studies can be designed to identify a lead candidate from several hits; develop the best procedure for new drug scale-up; select the best formulation; det...
Autores principales: | Steinmetz, Karen L, Spack, Edward G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697630/ https://www.ncbi.nlm.nih.gov/pubmed/19534731 http://dx.doi.org/10.1186/1471-2377-9-S1-S2 |
Ejemplares similares
-
Inferring novel disease indications for known drugs by semantically linking drug action and disease mechanism relationships
por: Qu, Xiaoyan A, et al.
Publicado: (2009) -
An alternative pathway for preclinical research in fluid management
por: Sibbald, William J
Publicado: (2000) -
BOAT: Basic Oligonucleotide Alignment Tool
por: Zhao, Shu-Qi, et al.
Publicado: (2009) -
Preclinical progression of neurodegenerative diseases
por: Katsuno, Masahisa, et al.
Publicado: (2018) -
Generation and application of drug indication inference models using typed network motif comparison analysis
por: Choi, Jaejoon, et al.
Publicado: (2013)